Zuprevo is a drug owned by INTERVET, INC. It is protected by 2 US drug patents filed from 2024 to 2029. Out of these, 1 patent is active and 1 patent has expired. Details of Zuprevo’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6514946 | 10 Sep, 2024 | Expired |
Exclusivity Information
Zuprevo holds 1 exclusivity out of which 1 has expired. Details of Zuprevo's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | May 14, 2017 |
About Zuprevo
Zuprevo is a drug
owned by INTERVET, INC.
Zuprevo uses
Tildipirosin as the active
ingredient.
Active Ingredient:
Zuprevo uses
Tildipirosin as the active ingredient.
Check out other Drugs and Companies using
Tildipirosin ingredient.